ViaDerma, Inc. (OTCMKTS:VDRM) Short Interest Down 86.1% in February

ViaDerma, Inc. (OTCMKTS:VDRM) was the recipient of a significant decline in short interest in February. As of February 28th, there was short interest totalling 12,400 shares, a decline of 86.1% from the February 13th total of 89,100 shares. Based on an average daily trading volume, of 2,825,700 shares, the short-interest ratio is presently 0.0 days.

ViaDerma Stock Performance

OTCMKTS:VDRM opened at $0.02 on Thursday. ViaDerma has a twelve month low of $0.00 and a twelve month high of $0.02. The firm’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.01.

About ViaDerma

ViaDerma, Inc operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company’s lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.